Genentech, Inc.

This study tests whether adding a personalized cancer vaccine (autogene cevumeran) and an immunotherapy drug (atezolizumab) to standard chemotherapy can help prevent pancreatic cancer from coming back after surgery. About 260 adults whose cancer was fully removed and who have no …

This study looks at the safety of a refillable eye implant (PDS) that delivers the drug ranibizumab for wet age-related macular degeneration. Researchers will check if the implant affects the health of cells on the inside of the cornea. About 188 people with wet AMD will take par…

This early-phase study tests a new experimental drug, RO7566802, alone or combined with another drug (atezolizumab) in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check safety and find the right dose. About 250 part…

This early-stage study tests a new medicine (RO7823653) given as an eye injection, alone or with another drug (faricimab), in people with diabetic macular edema (DME) — a condition that causes vision loss. The main goal is to check safety and how the drug behaves in the body. Abo…

This early-stage trial is testing a combination of two experimental drugs, cevostamab and elranatamab, in people with multiple myeloma that has returned or stopped responding to prior therapies. The main goals are to check the safety of the combination and find the best dose for …

This study tests an inhaled drug called GDC-6988 in people with lung conditions that cause thick mucus, such as COPD and non-cystic fibrosis bronchiectasis. The main goals are to check the drug's safety and how well it works. About 128 adults with stable disease will take part.

This study is a pregnancy registry that collects information from pregnant women who have taken mycophenolate (a drug used after organ transplants or for autoimmune diseases). The goal is to better understand the risks of birth defects and pregnancy complications linked to this m…